KW
AMGN icon

Keyvantage Wealth’s Amgen AMGN Stock Holding History

Keyvantage Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$537K Buy
1,527
+264
+21% +$94.1K 0.24% 61
2025
Q4 		$413K Buy
1,263
+5
+0.4% +$1.59K 0.18% 68
2025
Q3 		$355K Sell
1,258
-11
-0.9% -$3.19K 0.15% 72
2025
Q2 		$354K Sell
1,269
-103
-8% -$29.2K 0.16% 72
2025
Q1 		$428K Sell
1,372
-98
-7% -$28.9K 0.21% 64
2024
Q4 		$383K Buy
+1,470
New +$436K 0.27% 63

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Keyvantage Wealth's AMGN Position: Q1 2026 in Review

Keyvantage Wealth increased its Amgen (AMGN) stake by 21% in Q1 2026, buying an estimated $94.1K and bringing the position to 1,527 shares worth $537K. The position accounts for 0.24% of the portfolio, ranked #61.

Keyvantage Wealth first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Keyvantage Wealth held 1,527 shares of Amgen worth $537K as of Q1 2026.
  • Keyvantage Wealth bought 264 Amgen shares in Q1 2026, an estimated $94.1K.
  • Amgen made up 0.24% of Keyvantage Wealth's portfolio in Q1 2026, its #61 holding.
  • Keyvantage Wealth first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Keyvantage Wealth's 13F filing for Q1 2026, filed 5 May 2026.